Day and Night Closed-Loop Glycemic Control With Faster-Acting Insulin Aspart in Young Adults With Type 1 Diabetes Using DreaMed Glucositter - The Fast PHYSI-DREAM Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2017
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms The Fast PHYSI-DREAM Study
- 04 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Jul 2017 New trial record
- 11 Jul 2017 Status changed from not yet recruiting to recruiting.